Q3 2020

Filed Nov 10, 2020 · 10-Q · 41 days after period end · 0001493152-20-020935

Q3 2020 · 10-Q

Revenue—

Net Income

-$693.16K

N/M vs Q3 2019

EPS Diluted

$0.00

— vs Q3 2019

Operating Income-$598,455N/M

Operating Cash Flowderived-$296,648N/M

Same quarter

Metric	Q3 2020	Q3 2019	Q3 2018	Q3 2017
Revenue	—	$0.00	$140.76K	$27.22K
Net Income	-$693.16K	-$1.13M	-$206.98K	-$279.79K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR